Stock News

Enter Stock SymbolU.S. Biofuels Policy: Oil & Corn Industries Fight It OutFarm groups and ethanol organizations are angered by the sharp increase in exemptions provided by the Andrew Wheeler-led Environmental Protection Agency to the oil refiners.Fri, 13 Sep 2019 19:29:07 +0000 —Read more…Timing the Market, Is it Possible? - September 10, 2019Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?Tue, 10 Sep 2019 11:55:11 +0000 —Read more…Big Ag wants a cut of booming fake-meat marketWINNIPEG, Manitoba/CHICAGO (Reuters) - Bunge Ltd, one the world's biggest grain traders, recently disclosed the 1.6% stake it had purchased in the fast-growing fake-meat startup Beyond Meat. The play looked smart after the stock surged more than 250% since the faux burger and sausage maker's initial public offering in May. Indeed, Beyond Meat's market capitalization of $9.9 billion is now larger than Bunge's, a 201-year-old firm with 31,000 employees. No wonder many top agricultural firms want to grab their cut of the booming market for plant-based fake meat.Mon, 09 Sep 2019 10:28:25 +0000 —Read more…Lawsuit alleges ADM manipulated cash ethanol market to profit from derivativesGlobal grain trader and food processor Archer Daniels Midland Co allegedly manipulated the price of ethanol to profit from a short position it was holding in the derivatives market, according to a lawsuit by a rival firm. AOT Holdings, a Swiss company that owns an energy trading subsidiary, filed the class action complaint late on Wednesday in U.S. District Court's Central District of Illinois Urbana Division, claiming damages from ADM's actions of up to $6.33 million. The lawsuit follows reporting by Reuters last year that ADM's ethanol selling had led traders to complain to S&P Global Platts, which provides benchmark pricing for the physical ethanol contract at different U.S. delivery points including Chicago.Thu, 05 Sep 2019 17:09:13 +0000 —Read more…Are Investors Undervaluing Archer-Daniels-Midland Company (NYSE:ADM) By 42%?Today we will run through one way of estimating the intrinsic value of Archer-Daniels-Midland Company (NYSE:ADM) by...Mon, 02 Sep 2019 13:12:11 +0000 —Read more…ADM (ADM) Down 7.5% Since Last Earnings Report: Can It Rebound?ADM (ADM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.Sat, 31 Aug 2019 13:32:01 +0000 —Read more…ADM, Bunge say not sourcing from newly deforested parts of AmazonFri, 30 Aug 2019 17:50:45 +0000 —Read more…UPDATE 3-Brazil officials, Bolsonaro's son meet with Trump to discuss Amazon firesWASHINGTON/BRASILIA, Aug 30 (Reuters) - Brazil's foreign minister and President Jair Bolsonaro's son met with U.S. President Donald Trump on Friday to discuss the fires ravaging the Amazon rainforest, although no concrete measures to deal with the blazes were announced. Speaking to reporters following the meeting, Eduardo Bolsonaro said there could be an announcement later, potentially after his return to Brasilia on Saturday and consultations with his father. Bolsonaro has said he will appoint Eduardo as Brazil's ambassador to the United States, but the controversial nomination has yet to be sent to the Senate for voting and confirmation.Fri, 30 Aug 2019 13:03:45 +0000 —Read more…UPDATE 3-Signs of new U.S.-China trade discussions emerge as increased tariffs loomWASHINGTON/BEIJING, Aug 29 (Reuters) - The United States and China gave signs on Thursday that they will resume trade talks as the two economic superpowers discussed the next round of in-person negotiations in September ahead of a looming deadline for additional U.S. tariffs. A new round of U.S. tariffs on some Chinese goods is scheduled to take effect on Sunday, threatening to escalate an already bitter trade war. President Donald Trump said some discussions were taking place on Thursday, with more talks scheduled.Thu, 29 Aug 2019 08:42:45 +0000 —Read more…Meet 3 Companies that Are Shaping the Future of FoodBeyond Meat is just the beginning of a new emerging cohort of innovative companies. These innovators are changing how we feed the planet without consuming more of its resources.Tue, 27 Aug 2019 18:37:00 +0000 —Read more…Winners & Losers From the U.S.-China Trade ProblemThanks to the ever-changing China-trade narrative, the stock market continues to gyrate. Let us, thus, take a look at the potential winners and losers.Tue, 27 Aug 2019 13:41:01 +0000 —Read more…7 Stocks George Soros Continues to BuyArcher-Daniels Midland tops the list Continue reading...Wed, 21 Aug 2019 20:57:03 +0000 —Read more…Will Archer Daniels' Solid Growth Efforts Help Revive Stock?Archer Daniels' (ADM) weak Carbohydrate Solutions segment is concerning. However, the company's growth efforts including the Readiness program is likely to aid performance.Wed, 21 Aug 2019 14:07:02 +0000 —Read more…High-Dividend Stocks on Historic Discount as Yields Plunge, says GoldmanU.S. high-dividend stocks are trading at their biggest discount in four decades as investors flock to bonds, pushing down their yields.Tue, 20 Aug 2019 09:48:14 +0000 —Read more…Agriculture Operations Outlook: Tariffs to Mar Organic GainsAgriculture Operations Outlook: Tariffs to Mar Organic GainsMon, 19 Aug 2019 13:42:01 +0000 —Read more…Based On Its ROE, Is Archer-Daniels-Midland Company (NYSE:ADM) A High Quality Stock?Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...Thu, 15 Aug 2019 13:19:09 +0000 —Read more…Europe stocks hammered as German economy heads toward recessionEurope stocks traded sharpy lower on Wednesday after data showing the Continent’s largest economy contracted and eurozone industrial production declined.Wed, 14 Aug 2019 15:52:00 +0000 —Read more…7 Large-Cap Stocks to Sell Right NowThe market has been on a wild ride this week, and today won't be much different. But the fact is, there are a number of things going on around the globe that are signaling that a slowdown is underway, trade wars or not.The United Kingdom just announced that its economy has contracted. Germany's manufacturing is weakening. Many European Union nations are back to negative interest rates to spur investment. The United States is still doing all right, but the trade war is starting to have its costs. And if President Donald Trump's administration adds another $300 billion Chinese goods to the war, not even the easiest Federal Reserve policy may help.Adding to this, the U.S. dollar remains the strongest currency out there. And that's not good for multinational corporations or companies that rely on the strength or weakness of the dollar for their products.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 8 Dividend Aristocrat Stocks to Buy Now No Matter What Below are seven large-cap stocks to get out of your life now, before this all ends up in their next earnings reports. They're all F-rated in my Portfolio Grader. Large-Cap Stocks to Sell: Occidental Petroleum (OXY)Source: Shutterstock Occidental Petroleum (NYSE:OXY) is an integrated energy producer with exploration and production operations in the U.S., Colombia and the Middle East. It recently completed its $55 billion acquisition of Anadarko Petroleum. This deal left Occidental in debt when the company was forced to complete the payment in cash instead of stock. Now OXY has to divest all redundant business to get to the U.S. shale fields Anadarko owned.Add to this a slowing global economy, rising oil inventories and trouble in Venezuela -- Colombia's neighbor -- and you have a lot of headaches ahead.There's a reason OXY stock is off 23% this year and 40% in the past 12 months. FedEx (FDX)Source: Shutterstock FedEx (NYSE:FDX) is the well-known global shipping and logistics business. And it's having a rough go of it because of its far-flung empire.The U.S.-China trade war doesn't help and the strong dollar is a potential double whammy to its business since all revenue derived abroad is worth less when converted back to dollar terms. This is one of the big consequences facing U.S. companies doing business in China, especially now that China has lowered its yuan against the dollar.China's move has also lowered the Singapore dollar as well, since it trades in a close ratio to the yuan. In Europe, Brexit is hurting the British pound and most of the mainland is struggling with negative interest rates as their economies slow. * 10 Cyclical Stocks to Buy (or Sell) Now Add to that FedEx's recent announcement that it's ending its relationship with Amazon (NASDAQ:AMZN) and there's going to be some adjustment in expectations moving forward. Year-to-date, the stock is up less than 2%, and it's down 32% over the past year. Kraft Heinz (KHC)Kraft Heinz (NASDAQ:KHC) became the fifth-largest food company following its 2015 merger. But things haven't gone as expected.Over the past three years, the stock has been on a downward trajectory that at this point seems unstoppable. Kraft and Heinz used to be two bedrock consumer staples companies that owned some of the most iconic brands on supermarket shelves. But times have changed.Younger generations aren't as beholden to those brands and tastes and demographics have changed. As a new wave of non-European immigrants start to show their buying power, ketchup and mac and cheese are not the foundation of comfort foods they once were.While KHC stock still delivers an impressive nearly 5.7% dividend, it doesn't make up for a stock that dropped 34% year-to-date, and 53% in the past year -- as well as 68% in the past three years. Archer-Daniels-Midland (ADM)Source: Shutterstock Archer-Daniels-Midland (NYSE:ADM) is one of the largest publicly traded agricultural companies in the U.S. But this year hasn't been kind to farmers, and thus, to ADM.The latest escalation of the trade war saw China retaliate by swearing off all American agricultural products. Bear in mind, it took many years to establish the previous U.S.-China trade relationship.Now, China has leased land from Russia's far eastern region and is growing its own soybeans there. That isn't just a short-term fix, that's business that U.S. farmers may have lost forever.Add to that the flooding in the spring that made corn planting difficult -- if not impossible -- for Corn Belt farmers. But prices are still low and aren't helping farmers stabilize. The taxpayer-funded aid isn't a long-term solution and hardly covers the expenses many need to keep going. * 5 Cheap Stocks to Buy Now That the Fed Cut Rates ADM stock feels all of this. The stock is off 6% year-to-date and 23% in the past year. ArcelorMittal (MT)Source: Shutterstock ArcelorMittal (NYSE:MT) is the world's largest steel producer. That's usually a good thing, since it can balance between mining operations for iron ore and steel production. But when there's not a lot of growth going on, industrial commodities is the first sector that gets hit.Recently, the prices of iron ore and coking coal -- the two main inputs in steelmaking -- have risen, making steel even more expensive to produce. Add to that waning demand and it's hard to make a buck.MT stock's second-quarter earnings tell the story. The company lost nearly $500 million in Q2 after writing down almost $1 billion in impairments. With growth projections falling around the world and the dollar strong, it's not a good place to be right now.Off 30% year-to-date and 52% in the past year, MT stock is not a good choice now or in the near future. AbbVie (ABBV)Source: Shutterstock AbbVie (NYSE:ABBV) owns the world's most profitable prescription drug, Humira. Now, Humira became off-patent in 2016, but you wouldn't know that from the sales. Advertising for the drug also continues unabated. Why? Because ABBV went to court in both the U.S. and E.U. to fight to keep biosimilars, drugs that are nearly identical, out of the market for another seven years.And while the case made its way through courts over a couple years, E.U. courts allowed biosimilars to remain on the market through late 2018. The U.S. courts gave Humira its dominance (and pricing power) until 2023.While AbbVie has a stable of solid drugs out there, it's hard not to see Humira as its chief breadwinner. And that status is waning. Add to this threats from U.S. consumers and politicians to transition to a more consumer-focused healthcare system where prescription drug cost prices will be better negotiated. * 10 Stocks to Buy on the Trade War Dip This is all part of the reason why AbbVie recently offered to buy out Allergan (NYSE:AGN) for a whopping $63 billion. However, that deal has yet to get approved, and it will take a while to assimilate the acquisition if it does.All of these are real risks. Ryanair (RYAAY)Source: Shutterstock Ryanair (NASDAQ:RYAAY) is the world-renowned, low-fare airline of Europe. While plenty of people have tried before to capture that market, RYAAY has had the most enduring success.But, the airline has come up against an immovable force that may not spell doom for the company, but certainly has chilled investors' enthusiasm. The airline has had to suspend about 30,000 flights because it was a big customer for Boeing's (NYSE:BA) 737 MAX 8 planes. When that model was taken out of the sky, it impacted many airlines. But RYAAY got hit significantly, since its entire business is ferrying people around Europe for bargain prices.It can't expand service now and the savings new jets would bring in efficiencies are no longer there. Those 30,000 flights represent five million passengers. Ryanair also has to cut back operations at airports and close some of its hubs.This is a significant disruption to an airline that was already running a business on thin margins and high volume. And there's still no sign when the airplanes will be cleared for take off.Off 13% year-to-date and 38% in the past 12 months, this stock is going to have trouble achieving cruising altitude for some time.Louis Navellier had an unconventional start, as a grad student who accidentally built a market-beating stock system -- with returns rivaling even Warren Buffett. In his latest feat, Louis discovered the "Master Key" to profiting from the biggest tech revolution of this (or any) generation. Louis Navellier may hold some of the aforementioned securities in one or more of his newsletters. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 8 Dividend Aristocrat Stocks to Buy Now No Matter What * 7 Stocks to Buy to Ride the Vegan Wave * 4 Safe Stocks to Buy Amid Trade War Turbulence The post 7 Large-Cap Stocks to Sell Right Now appeared first on InvestorPlace.Fri, 09 Aug 2019 18:59:06 +0000 —Read more…

MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.

This company makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.

The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The www.MarketTamer.com educational training program and software services are provided to improve financial understanding.

The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.

Disclaimer: Past performance is no guarantee of future performance. This product is for educational purposes only. Practical application of the products herein are at your own risk and MarketTamer.com, its partners, representatives and employees assume no responsibility or liability for any use or mis-use of the product. Please contact your financial advisor for specific financial advice tailored to your personal circumstances. Any trades shown are hypothetical example and do not represent actual trades. Actual results may differ. Nothing here in constitutes a recommendation respecting the particular security illustrated.